Vital

Tracker apps

GLP-1 and Peptide Tracker: One Log for Your Stack

How to keep a weekly GLP-1 such as tirzepatide and daily peptides such as BPC-157 in one GLP-1 and peptide tracker, what each entry must record, and how Vital shows every item in one list.

Last reviewed

The Vital angle

Vital shows every saved pen, vial, and stack in one home list, the cabinet, with today's status for each item: due now, due later, taken, or next due. Each item keeps its own reminder, which can repeat on set weekdays, every few days, or more than once a day, and a stack keeps each compound's mass and the water so each logged draw shows the amount of each compound. All doses share one site history on a body map and export to one PDF.

Why use one GLP-1 and peptide tracker

A GLP-1 and peptide tracker keeps every injection in one log: a weekly GLP-1 such as tirzepatide or semaglutide, plus any daily or every-few-days peptides. One log shows what you took, when, where, and how you felt, in one timeline. When you use two apps, or an app plus a notebook, it is hard to see which item came before a side effect.

A good multi-medication injection app needs four things. Each item has its own schedule. Each item keeps its own units, because a pen in mg and a vial drawn in syringe units are different. All items share one injection site history, so rotation works across every shot. All logs export to one report for your prescriber. The rest of this guide shows how to set that up, and what to watch for.

What a combined log must record

Record the same fields for every item, whether it is a pen or a vial:

Field Weekly GLP-1 pen Vial or peptide drawn by syringe
Name Medication and strength on the pen Compound name, or each compound in a blend
Amount mg on the pen mg or mcg, plus the draw in units and mL
Vial strength Not needed for a pen Powder mass and water added, giving mg/mL
Schedule Weekday and time Every day, set weekdays, or every few days
Site Abdomen, thigh, or upper arm Same site history, so you rotate across all shots
Effects Symptoms and severity with a date Same
Batch Lot and expiration date Lot, expiration, and the date you mixed the vial

The Zepbound label lists a starting dosage of 2.5 mg once weekly for 4 weeks, then increases in 2.5 mg steps after at least 4 weeks, up to a maximum of 15 mg once weekly. Your prescriber picks each step. A log that records the step and the date makes each change easy to see.

For vials, the units are where errors happen. The FDA reported dosing errors with compounded semaglutide where people mixed up mg, mL, and units. In one case, patients told to draw 5 units drew 50. Keep the vial strength next to every draw, and confirm every draw with your prescriber or pharmacist. The free peptide calculator shows the math, and how to reconstitute peptides with BAC water explains the mixing math.

Regulatory status of common stack peptides

Tirzepatide and semaglutide are FDA-approved in brand products such as Zepbound, Mounjaro, Wegovy, and Ozempic. Many peptides that people add to a GLP-1 are not approved for any use.

The FDA lists BPC-157, TB-500 (a thymosin beta-4 fragment), CJC-1295, KPV, and injectable GHK-Cu among bulk drug substances that may present significant safety risks in compounding. For several of them, it cites possible immune reactions from impurities or aggregation, and limited or no human safety data. For CJC-1295, it notes reported serious adverse events, including a fast heart rate. Ipamorelin is also on the list.

No approved human dose exists for these compounds, and this page gives none. A tracker records what your care team set. It does not make a stack safe, and it is not evidence that two compounds work well together. Tell your prescriber about every item you take, including supplements. See stacking peptides with GLP-1 and Wolverine stack: BPC-157 and TB-500.

How Vital shows a GLP-1 and peptide stack in one list

Vital puts every saved pen, vial, and stack on the home screen as one list, called the cabinet. Each item shows its status for today: due now, due later, taken, or next due. Items that are due now sort to the top, so a daily peptide and a weekly shot on the same morning both show where you can see them.

You add each item by scanning the label, choosing it from the library, or typing it. Then you set a reminder for that item. Reminders can repeat on set weekdays, every few days, or at more than one time per day, and each one can arrive as a notification or an alarm. A weekly GLP-1 and a daily peptide each keep their own schedule.

For a course with an end, such as a peptide your prescriber set for a fixed number of weeks, you can set a course with a duration or leave it ongoing. A progress bar shows where you are in the course.

Tracking a blend next to your GLP-1

If a vial holds more than one compound, Vital saves it as a stack. You enter each compound and its mass, the bacteriostatic water, and your usual draw. When you log a dose from the stack, the log shows the amount of each compound in that draw.

Math example with hypothetical round numbers, not a dose: a vial with 10 mg of compound A and 10 mg of compound B, mixed with 2 mL of water, holds 5 mg/mL of each. A draw of 0.1 mL, which is 10 units on a U-100 syringe, holds 0.5 mg of each compound. Confirm every draw with your prescriber or pharmacist.

This is also why a separate log for each compound in a blend is a problem. One injection is one event. If you log it as two entries in two apps, the site and the time can drift apart. See peptide injection log template and KLOW peptide blend guide.

Site rotation across every shot

When you inject a weekly GLP-1 and a daily peptide, you inject eight or more times a week. Rotation must cover all of those shots, not each item alone. Vital records the site with every dose and shows the history on a body map, so the next shot can go to a site you have not used recently.

If a site gets red, hard, or painful, note it in the log and ask your prescriber. See injection site rotation chart and peptide injection site reaction.

Side effects and timing

A combined log helps you and your prescriber see patterns. Vital lets you tag each dose with symptoms such as nausea, reflux, constipation, fatigue, or an injection site reaction, with a severity. A "still in your system" card shows a half-life estimate after each dose. The free GLP-1 level chart plots a longer estimate.

GI side effects are common with GLP-1 drugs, and they often follow a dose increase. If you started a new peptide in the same week as a GLP-1 step, the log shows that overlap. Bring the PDF dose history from Vital's Settings to the visit. See GLP-1 side effects and dose log for a doctor visit.

Urgent warning signs

Do not wait for the next visit if you have any of these. Get care right away:

  • Severe stomach pain that does not go away, with or without vomiting.
  • Swelling of the face, lips, tongue, or throat, or trouble breathing.
  • Vomiting or diarrhea that stops you from keeping fluids down.
  • Pain in the upper right belly, fever, or yellow skin or eyes.
  • A fast heartbeat at rest that does not slow down, or chest pain.

Vital is a tracking tool, not a medical device. It does not recommend doses or stacks. Compare it with other apps in best peptide tracker app and best GLP-1 tracker app.


Wegovy®, Ozempic® are trademarks of Novo Nordisk A/S. Mounjaro®, Zepbound® are trademarks of Eli Lilly and Company. Vital is independent and not affiliated with these companies.

Free toolPeptide reconstitution calculator

Things to watch

Practical flags drawn from prescribing information and clinical guidance. Vital surfaces these in the dose log to help you spot them early.

  • Unapproved stack peptides

    The FDA lists BPC-157, TB-500, CJC-1295, KPV, ipamorelin, and injectable GHK-Cu among bulk substances that may present significant safety risks, with limited or no human safety data. No approved human dose exists.

  • Units without a vial strength

    A syringe unit is a volume mark. The FDA reported overdoses from mixing up mg, mL, and units, including a draw of 50 units instead of 5. Keep the mg/mL next to every draw.

  • Two apps for one routine

    Split logs hide which item came before a side effect and break site rotation across shots. Keep every injection in one timeline.

  • Starting two changes at once

    A new peptide in the same week as a GLP-1 dose step makes it hard to tell what caused a side effect. Ask your prescriber about the timing of every change.

  • Community or vendor protocols

    Forum and vendor stacks are not prescriptions. Tell your prescriber about every item you take and follow only the plan they set.

Frequently asked questions

  • Yes, in a tracker that supports custom peptides. In Vital, each item keeps its own schedule and units, and all doses share one timeline and site history. BPC-157 is not an approved drug, so ask your prescriber about it.

  • It is an app that logs a GLP-1 together with other peptides. It keeps a separate schedule and unit for each item, one injection site history for all shots, and one report for your prescriber.

  • Save each one as its own item with its own reminder. A weekly reminder on a set weekday and a daily reminder can run side by side. The log then shows both in one timeline.

  • Record each compound's mass, the water added, and the volume you draw. In Vital, a stack keeps these values and shows the amount of each compound in each logged draw. Confirm the draw with your pharmacist.

  • There is no approved guidance for combining unapproved peptides with GLP-1 drugs, and the FDA notes limited human safety data for several of them. Tell your prescriber about every item before you start.

  • Yes, if all shots share one site history. Vital records the site with every dose and shows it on a body map, so rotation covers the GLP-1 and the peptides together.

Sources

  1. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks · U.S. Food and Drug Administration
  2. Zepbound (tirzepatide) injection prescribing information · DailyMed, U.S. National Library of Medicine
  3. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products · U.S. Food and Drug Administration
  4. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss · U.S. Food and Drug Administration
  5. Vital - Track Peptide & GLP-1 · App Store

This page summarizes publicly available information from the sources listed above and is for educational use only. It is not medical advice. Consult a qualified healthcare professional for personal dosing guidance.

Track every shot, every change

Vital logs every GLP-1 injection and peptide dose, then surfaces patterns your scale can't show. Free on iOS and Android.